Irish Medicines Database — 10,165 HPRA-Authorised Products

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

491 results for “Novo”

Medicine	Active substance	Licence holder	Status
Abiraterone Krka 500 mg film-coated tablets EU/1/21/1553/001-003	Abiraterone acetate	KRKA, d.d., Novo mesto	—
Activelle 1 mg/0.5 mg film-coated tablets PA0218/052/001	Estradiol, Norethisterone acetate	Novo Nordisk A/S	Marketed
Actraphane EU/1/02/229/001-035	Insulin human	Novo Nordisk A/S	—
Actraphane 30 40 IU/ml Suspension for injection EU/1/02/229/036-037	Insulin human, Insulin human	Novo Nordisk A/S	—
Actrapid EU/1/02/230/001-015	Insulin human	Novo Nordisk A/S	—
Actrapid EU/1/02/230/016-017	Insulin human	Novo Nordisk A/S	—
Alhemo 15 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/001-002	Concizumab	Novo Nordisk A/S	—
Alhemo 150 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/005-006	Concizumab	Novo Nordisk A/S	—
Alhemo 300 mg/3 mL solution for injection in pre-filled pen EU/1/24/1881/007	Concizumab	Novo Nordisk A/S	—
Alhemo 60 mg/1.5 mL solution for injection in pre-filled pen EU/1/24/1881/003-004	Concizumab	Novo Nordisk A/S	—
Alprazolam Krka 1 mg tablets PA1347/097/003	Alprazolam	KRKA, d.d., Novo mesto	Marketed
Alprazolam Krka 250 microgram tablets PA1347/097/001	Alprazolam	KRKA, d.d., Novo mesto	Marketed
Alprazolam Krka 500 microgram tablets PA1347/097/002	Alprazolam	KRKA, d.d., Novo mesto	Marketed
Amlodipine Krka 10 mg Tablets PA1347/034/002	Amlodipine	KRKA, d.d., Novo mesto	Marketed
Amlodipine Krka 5 mg Tablets PA1347/034/001	Amlodipine	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan Krka 10 mg/160 mg film-coated tablets PA1347/055/003	Amlodipine, Valsartan	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan Krka 10 mg/320 mg film-coated tablets PA1347/055/005	Amlodipine, Valsartan	KRKA, d.d., Novo mesto	Not marketed
Amlodipine/Valsartan Krka 5 mg/ 160 mg film-coated tablets PA1347/055/002	Amlodipine, Valsartan	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan Krka 5 mg/ 80 mg film-coated tablets PA1347/055/001	Amlodipine, Valsartan	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan Krka 5 mg/320 mg film-coated tablets PA1347/055/004	Amlodipine, Valsartan	KRKA, d.d., Novo mesto	Not marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 10 mg/160 mg/12.5 mg film-coated tablets PA1347/106/002	Amlodipine, Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 5 mg/160 mg/12.5 mg film-coated tablets PA1347/106/001	Amlodipine, Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Amlodipine/Valsartan/Hydrochlorothiazide Krka 5 mg/160 mg/25 mg film-coated tablets PA1347/106/003	Amlodipine, Valsartan, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Amoxicillin/clavulanic acid Krka 500 mg/125 mg Film-Coated Tablets PA1347/044/001	Amoxicillin, Clavulanic acid	KRKA, d.d., Novo mesto	Not marketed
Apeneta 100 mg prolonged-release tablets PA1347/105/002	Tapentadol maleate hemihydrate	KRKA, d.d., Novo mesto	Marketed
Apeneta 150 mg prolonged-release tablets PA1347/105/003	Tapentadol maleate hemihydrate	KRKA, d.d., Novo mesto	Marketed
Apeneta 200 mg prolonged-release tablets PA1347/105/004	Tapentadol maleate hemihydrate	KRKA, d.d., Novo mesto	Marketed
Apeneta 250 mg prolonged-release tablets PA1347/105/005	Tapentadol maleate hemihydrate	KRKA, d.d., Novo mesto	Marketed
Apeneta 50 mg prolonged-release tablets PA1347/105/001	Tapentadol maleate hemihydrate	KRKA, d.d., Novo mesto	Marketed
Apixaban Krka 2.5 mg film-coated tablets PA1347/107/001	Apixaban	KRKA, d.d., Novo mesto	Not marketed
Apixaban Krka 5 mg film-coated tablets PA1347/107/002	Apixaban	KRKA, d.d., Novo mesto	Not marketed
Apremilast Krka 10 mg film-coated tablets Apremilast Krka 20 mg film-coated tablets Apremilast Krka 30 mg film-coated tablets PA1347/114/001	Apremilast, Apremilast, Apremilast	KRKA, d.d., Novo mesto	Not marketed
Apremilast Krka 30 mg film-coated tablets PA1347/114/002	Apremilast	KRKA, d.d., Novo mesto	Marketed
Aripiprazole Krka 10mg Tablets PA1347/089/002	Aripiprazole	KRKA, d.d., Novo mesto	Marketed
Aripiprazole Krka 15mg Tablets PA1347/089/003	Aripiprazole	KRKA, d.d., Novo mesto	Marketed
Aripiprazole Krka 30mg Tablets PA1347/089/004	Aripiprazole	KRKA, d.d., Novo mesto	Marketed
Aripiprazole Krka 5mg Tablets PA1347/089/001	Aripiprazole	KRKA, d.d., Novo mesto	Marketed
Aspirin Krka 75 mg gastro-resistant tablets PA1347/070/001	Acetylsalicylic acid	KRKA, d.d., Novo mesto	Marketed
Atorvastatin Krka 10 mg film-coated tablets PA1347/023/001	Atorvastatin	KRKA, d.d., Novo mesto	Marketed
Atorvastatin Krka 20 mg film-coated tablets PA1347/023/002	Atorvastatin	KRKA, d.d., Novo mesto	Marketed
Atorvastatin Krka 40 mg film-coated tablets PA1347/023/003	Atorvastatin	KRKA, d.d., Novo mesto	Marketed
Atorvastatin Krka 80 mg film-coated tablets PA1347/009/004	Atorvastatin	KRKA, d.d., Novo mesto	Marketed
Awiqli 700 units/mL solution for injection in pre-filled pen EU/1/24/1815/001-014	Insulin icodec	Novo Nordisk A/S	—
Azithromycin Krka 250 mg film-coated tablets PA1347/047/001	Azithromycin	KRKA, d.d., Novo mesto	Not marketed
Bisoprolol Krka 10 mg film-coated tablets PA1347/031/003	BISOPROLOL FUMARATE	KRKA, d.d., Novo mesto	Marketed
Bisoprolol Krka 2.5 mg film-coated tablets PA1347/031/001	BISOPROLOL FUMARATE	KRKA, d.d., Novo mesto	Marketed
Bisoprolol Krka 5 mg film-coated tablets PA1347/031/002	BISOPROLOL FUMARATE	KRKA, d.d., Novo mesto	Marketed
Candesartan Hydrochlorothiazide Krka 16mg/12.5mg tablets PA1347/011/002	Candesartan cilexetil, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Marketed
Candesartan Hydrochlorothiazide Krka 32mg/12.5mg tablets PA1347/011/003	Candesartan cilexetil, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Not marketed
Candesartan Hydrochlorothiazide Krka 32mg/25mg Tablets PA1347/011/004	Candesartan cilexetil, Hydrochlorothiazide	KRKA, d.d., Novo mesto	Not marketed

1 2 3 4 →

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.